Total Visits

Views
RENACER study: Assessment of 12-month efficacy and safety of 168 certolizumab PEGol rheumatoid arthritis-treated patients from a Spanish multicenter national database45

Select a period of time:

Views

Views
January 20251
February 20254
March 202515
April 20252
May 202510
June 20250
July 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
Hong Kong10
United States6
Spain1
 

Top cities views

Views
Hong Kong10
Council Bluffs1
Los Angeles1
Orangeburg1
Scottsdale1